K-numberK241910
Device nameNeonav ECG Tip Location System
ApplicantNavi Medical Technologies
Product codeLJS
Device classClass II
Decision dateJan 19, 2025
DecisionSubstantially Equivalent
Regulation880.5970
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Neonav ECG Tip Location System is a non-invasive device that analyzes electrocardiographic signals to track the real-time position of central venous access devices (CVADs) during placement and post-placement. It provides an alternative to chest X-ray and fluoroscopy for confirming catheter tip location across multiple patient populations from neonates through adults, with limitations in patients with altered cardiac rhythms such as atrial fibrillation or pacemaker-driven rhythms.

Technological characteristics

Neonav has equivalent features and materials to the predicate device but includes several notable differences: it does not have a printer (reports copied to USB instead), maintains separate remote and acquisition units rather than a single item, uses a wired USB connection instead of wireless Bluetooth, is a standalone application rather than mobile-based, displays intravascular ECG signals for user interpretation rather than computing automated navigation, and can display multiple frozen ECG waveforms simultaneously with insertion depth and spot-check readings.

Test standards cited

ISO 10993-1 (biological evaluation), ISO 11135-1 and ISO 11135-7 (ethylene oxide sterilization), ISO 11607 and ISO 16407 (packaging for sterilized devices), ISO 15223-1 (medical device symbols), ISO 14971 (risk management), IEC 60601-1-2, IEC 60601-1-6, IEC 62366-1, IEC 62304 (software), IEC 60601-2-27 (electrocardiographic monitoring equipment), ISO 80369-7 (small-bore connectors), ANSI/AAMI EC53, ASTM standards for chemical resistance and packaging, and FDA guidance documents on software, cybersecurity, and human factors.

Substantial equivalence argument

Neonav demonstrates substantial equivalence to the predicate (Nautilus Delta) based on identical intended use for navigation and positioning of CVADs as an alternative to imaging, equivalent indications across patient populations from neonates to adults, and equivalent technological characteristics and materials despite cosmetic and interface differences. The performance testing validated that Neonav meets all predetermined acceptance criteria per recognized consensus standards, confirming that the functional differences (such as user-interpreted ECG display versus automated computation) remain within the scope of the intended use for supporting catheter tip positioning decisions without raising new safety or effectiveness questions.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →